Simavita Limited: Release Of Restricted Securities

SYDNEY, AUSTRALIA--(Marketwired - Feb 5, 2016) - Simavita Limited (SVA.AX)(TSX VENTURE:SV) (“Simavita” or the “Company”) announces the release of restricted securities from ASX escrow (Restricted Securities).

In accordance with ASX listing rule 3.10A, the following Restricted Securities will be released from ASX escrow on 19 February 2016.

361,392 common shares
1,469,166 options, exercisable at AUD$0.41, with an expiry date of 3 December 2016.
2,469,166 options, exercisable at AUD$0.52, with an expiry date of 3 December 2016.
1,469,166 options, exercisable at AUD$0.65, with an expiry date of 3 December 2016.
1,469,166 options, exercisable at AUD$0.82, with an expiry date of 3 December 2016.
1,154,245 warrants, exercisable at AUD$0.41 and with an expiry date of 3 December 2016.

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM®

SIM® is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM® provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM® is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM®, please visit www.simavita.com.

MORE ON THIS TOPIC